Andon Health's (SHE:002432) U.S. subsidiary iHealth Labs received premarket notifications for its upper respiratory tract virus test kits, according to a Monday filing with teh Shenzhen bourse.
The test kits determine the presence of influenza A and B, COVID-19, and respiratory syncytial virus, the filing said.
The premarket notifications mean they can be sold in the U.S., the filing said.